Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A [The Motley Fool]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: The Motley Fool
Here's what derailed the drug, and why Illumina is paying $1.2 billion to acquire Pacific Biosciences. Millions of Americans suffer from depression, and there's a big unmet need for new depression drugs because about one-third of patients don't respond adequately to existing treatment options. To fill that need, Alkermes ( NASDAQ:ALKS ) developed ALKS-5461, a once-daily pill that combines an opioid with a compound that can prevent addiction. Unfortunately, missteps in ALKS-5461's trial design and less-than-convincing efficacy appear to have dashed the drug's chances of approval because a key Food and Drug Administration (FDA) advisory committee just voted overwhelmingly against approving it. In this episode of Industry Focus: Healthcare , analyst Shannon Jones and specialist Todd Campbell explain why these experts object to ALKS-5461, and what investors should be watching at Alkermes next. Also, Jones and Campbell explain why Illumina ( NASDAQ:ILMN ) is expan
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Carbon Dioxide Incubator Market Projected to Reach $1,284.66 million by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- Global Spectrometry Market Projects Robust Growth Through 2029 with Advancements in Analytical Technologies [Yahoo! Finance]Yahoo! Finance
- Global Glow Cell Assay Reagents Market Poised for Robust Growth and Technological Advancements by 2028 [Yahoo! Finance]Yahoo! Finance
- Global Immunoprecipitation Testing Market Industry Trends & 10 Year Growth Forecasts 2019-2029 [Yahoo! Finance]Yahoo! Finance
- Here's Why Investors Should Retain Thermo Fisher (TMO) Stock [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/31/24 - Beat
TMO
Sec Filings
- 3/27/24 - Form 4
- 3/14/24 - Form 4
- 3/13/24 - Form 4
- TMO's page on the SEC website